Aktis Oncology, Inc. (AKTS) Insider Trading

Name: Aktis Oncology, Inc. (AKTS) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 24, 2026): Czibere Akos (Chief Medical Officer): Exercise/Conversion of 12,500 shares, $61.9K.

Get alerted when insiders trade AKTS

Email address

Loading company data...

Beta

Loading company details...

Beta